| Molecular formula | C225H360N76O67S |
|---|
| Molecular weight | 5234 g/mol |
|---|
| Registered trials | 372 |
|---|
| PubChem CID | 16132356 |
|---|
What somatropin recombinant is
Somatropin recombinant is a large peptide compound identified in PubChem (CID 16132356), with a molecular formula of C225H360N76O67S and a molecular weight near 5234. There is no approved drug label on file for this entry, so no FDA-sanctioned indication, dosing, or safety information can be summarized here. It should be understood as a compound under clinical investigation rather than a marketed product.
Trial footprint
Public registries list 372 trials associated with somatropin recombinant. Among the sampled studies, one completed Phase 3 trial examined its effect on height velocity in subjects with idiopathic short stature. Other sampled trials include a completed Phase 2 study evaluating it as an add-on treatment in severe fibromyalgia with low IGF-1 levels, and a completed Phase 1/Phase 2 study looking at its use alongside rosiglitazone for HIV-associated abdominal fat and insulin resistance. These examples illustrate the range of conditions studied, not established outcomes or approved uses.
FAQ
No approved label is on file for this entry, so it should be regarded as a research compound rather than an approved medication. Any approved growth hormone products would carry their own separate labeling.
It is a large peptide with the molecular formula C225H360N76O67S and a molecular weight of approximately 5234. This size and composition are consistent with a protein-based hormone structure.
Public registries show 372 trials associated with this compound. These span multiple conditions and phases, reflecting broad research interest rather than a single confirmed use.
Sampled trials include research on idiopathic short stature, severe fibromyalgia with low IGF-1 levels, and HIV-associated abdominal fat with insulin resistance. These are examples of studied conditions, not confirmed or approved uses.
No adverse event report data is available for this entry, so no side effect pattern can be summarized here.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem CID 16132356 ClinicalTrials.gov registry data NCT01778023 NCT00497562 NCT00130286
Updated 2026-11-07